Connect Biopharma Holdings Ltd. (CNTB)
0.6652
+0.09
(+14.93%)
USD |
NASDAQ |
Nov 18, 16:00
0.6548
-0.01
(-1.56%)
After-Hours: 20:00
Connect Biopharma Holdings Price to Book Value : 1.560 for Nov. 18, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 1.560 |
| November 17, 2026 | 1.357 |
| November 16, 2026 | 1.508 |
| November 13, 2026 | 1.588 |
| November 12, 2026 | 1.560 |
| November 11, 2026 | 1.615 |
| November 10, 2026 | 1.599 |
| November 09, 2026 | 1.759 |
| November 06, 2026 | 1.708 |
| November 05, 2026 | 1.715 |
| November 04, 2026 | 1.830 |
| November 03, 2026 | 1.815 |
| November 02, 2026 | 1.822 |
| October 30, 2026 | 1.881 |
| October 29, 2026 | 1.958 |
| October 28, 2026 | 1.982 |
| October 27, 2026 | 1.975 |
| October 26, 2026 | 1.990 |
| October 23, 2026 | 1.797 |
| October 22, 2026 | 1.787 |
| October 21, 2026 | 1.871 |
| October 20, 2026 | 2.052 |
| October 19, 2026 | 2.110 |
| October 16, 2026 | 2.125 |
| October 15, 2026 | 2.124 |
| Date | Value |
|---|---|
| October 14, 2026 | 2.131 |
| October 13, 2026 | 2.154 |
| October 12, 2026 | 2.123 |
| October 09, 2026 | 2.040 |
| October 08, 2026 | 2.065 |
| October 07, 2026 | 2.215 |
| October 06, 2026 | 2.123 |
| October 05, 2026 | 2.105 |
| October 02, 2026 | 2.173 |
| October 01, 2026 | 2.297 |
| September 30, 2026 | 2.579 |
| September 29, 2026 | 2.326 |
| September 28, 2026 | 2.532 |
| September 25, 2026 | 2.532 |
| September 24, 2026 | 2.579 |
| September 23, 2026 | 2.509 |
| September 22, 2026 | 2.848 |
| September 21, 2026 | 3.095 |
| September 18, 2026 | 3.001 |
| September 17, 2026 | 3.024 |
| September 16, 2026 | 2.907 |
| September 15, 2026 | 2.743 |
| September 14, 2026 | 4.044 |
| September 11, 2026 | 4.783 |
| September 10, 2026 | 4.830 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Anavex Life Sciences Corp. | 0.593 |
| Vaxcyte, Inc. | 3.510 |
| Foghorn Therapeutics, Inc. | -- |
| Caribou Biosciences, Inc. | 0.4597 |
| Oncolytics Biotech, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 13.02 |
| PEG Ratio | -0.003 |
| Price | 0.6652 |
| Earnings Yield | -179.8% |
| Market Cap | 41.89M |
| PEGY Ratio | -0.003 |